Mode
Text Size
Log in / Sign up
N/A N=214 Randomized Double-blind Prevention

Hypotension Prediction Index for Blood Pressure Management

Intraoperative Hypotension

Enrolled (actual)
214
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcome: Primary: Time- Weighted Average (TWA) MAP Under a Threshold of 65 mmHg. — 0.14; 0.14 mmHg — p=0.757

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Acumen HPI-enabled EV1000 screen (Device); Control (Device)
Age
Adult, Older Adult · 45+ yrs
Sex
All
Sponsor
The Cleveland Clinic
Primary completion
Jun 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Time- Weighted Average (TWA) MAP Under a Threshold of 65 mmHg.
0.14; 0.14 0.757
PRIMARY
Hypotension Severity (AUC-MAP) Under a Threshold of 65.
34.2; 32.7 0.715
PRIMARY
Duration of MAP Under a Threshold of 65 mmHg.
9.3; 7.7 0.328
SECONDARY
Time-weighted Average MAP Below a Threshold of 60 mmHg Per Case
0.02; 0.03 0.376
SECONDARY
Time-weighted Average MAP Below a Threshold of 55 mmHg Per Case
0; 0 0.226
SECONDARY
Hypotension Severity (AUC-MAP) Under a Threshold of 60 mmHg.
5.3; 6.0 0.610
SECONDARY
Hypotension Severity (AUC-MAP) Under a Threshold of 55 mmHg.
0.17; 1.00 0.302
SECONDARY
Duration of MAP Under a Threshold of 60 mmHg.
2.0; 2.0 0.889
SECONDARY
Duration of MAP Under a Threshold of 55 mmHg.
0.17; 0.67 0.403

Summary

Design: Single-center randomized comparison of invasive arterial pressure monitoring vs. arterial pressure monitoring combined with Acumen Hypotension Prediction Index (HPI) software guidance on intraoperative hypotension duration and severity. Aim: To determine whether use of Acumen HPI software guidance to guide intraoperative hemodynamic management in the non-cardiac surgery reduces the duration and severity of hypotension. Primary hypothesis: Our primary hypothesis is that adding Acumen HPI software guidance to the information provided by the invasive arterial pressure monitoring during moderate- to high-risk noncardiac surgery reduces time-weighted average (TWA) intraoperative hypotension below a threshold of 65 mmHg.

Eligibility Criteria

Inclusion Criteria

  • Written informed consent
  • Age ≥45 years
  • ASA Physical Status 3 or 4
  • Moderate- or high-risk surgery (for example, orthopedic, spine, urology, and general surgery)
  • Planned invasive blood pressure monitoring
  • General anesthesia
  • Surgery duration expected to last >2 hours
  • Planned overnight hospitalization

Exclusion Criteria

  • Contraindication to the invasive blood pressure monitoring
  • Pregnancy
  • Emergency surgery
  • Known clinically important intracardiac shunts
  • Known aortic stenosis with valve area ≤ 1.5 cm2
  • Known moderate to severe aortic regurgitation
  • Known moderate to severe mitral regurgitation
  • Known moderate to severe mitral stenosis
  • Patient or surgical procedure type known as an SVV limitation16 (e.g. tidal volume <8mL/kg of theoretical ideal weight, spontaneous ventilation, persistent cardiac arrhythmia, known atrial fibrillation, open chest surgery, Heart Rate/Respiratory Rate (HR/RR) ratio <3.6)
  • Current persistent atrial fibrillation
  • Congestive heart failure with ejection fraction <35%
  • Neurosurgery
  • Emergent or cardiovascular surgical procedure
  • Patient who is confirmed to be pregnant
  • Refusal of patient or authorized representative to sign consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03610165). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search